FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

Food and Drug Administration Commissioner Dr. Martin A. Makary announced that the FDA is filing a federal register notice to change the label on Leucovorin, so it can be prescribed to treat children with autism. Dr. Makary made the announcement Monday at the White House when President Trump, flanked by his leadership team at Health and Human Services, linked autism to the use of painkiller acetaminophen during pregnancy. Leucovorin, also known as folinic acid, is an active metabolite of folic acid, or vitamin B9. “You know, autism may also be...